...
首页> 外文期刊>Biological & pharmaceutical bulletin >Effects of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) and its analogues (EB1089 and analog V) on canine adenocarcinoma (CAC-8) in nude mice.
【24h】

Effects of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) and its analogues (EB1089 and analog V) on canine adenocarcinoma (CAC-8) in nude mice.

机译:1,25-二羟基维生素D3(1,25(OH)2D3)及其类似物(EB1089和类似物V)对裸鼠犬腺癌(CAC-8)的影响。

获取原文
获取原文并翻译 | 示例

摘要

The aim of this study is to determine the effects of 1,25(OH)2D3 and its analogues on tumor growth and body weight, changes in plasma ionized calcium, parathyroid hormone-related protein (PTHrP) production, bone resorption, and the distribution of the 1,25(OH)2D3 receptor (VDR) on tumors in nude mice-bearing the canine adenocarcinoma (CAC-8). Thirty-seven nude mice were implanted subcutaneously with CAC-8. Two weeks after implantation, the mice were divided into 5 groups and injected intraperitoneally 3 times/week for 4 weeks with 5 different substrates. Group I (nontumor-bearing mice) were injected with vehicle. Groups II through V were CAC-8-bearing mice injected with the following: Grp. II, vehicle; Grp. III, analog V; Grp. IV, 1,25(OH)2D3; and Grp. V, EB1089. Our results showed that mice body weight (% change) of CAC-8-bearing mice was significantly lower than those of nontumor-bearing mice (p<0.05). CAC-8-bearing mice treated with analog V maintained their body weight better than CAC-8-bearing mice treated with either vehicle, 1,25(OH)2D3, or EB1089. A reduction of tumor growth was observed in CAC-8-bearing mice treated with 1,25(OH)2D3 and its analogues; however, the reduction was not statistically significant compared to the vehicle-treated CAC-8-bearing mice. All CAC-8-bearing mice increased osteoclastic bone resorption and hypercalcemia. Immunohistochemical staining of CAC-8 with VDR antibody demonstrated a positive reaction in nuclei of tumor cells. In conclusion, CAC-8-bearing mice treated with analog V were more active and maintained their body weight better than other CAC-8-bearing groups. Analog V-treated mice also showed no toxic side effects of hypercalcemia despite an increase in plasmaionized calcium comparable to nontumor-bearing mice. Tumor volumes of CAC-8-bearing mice treated with 1,25(OH)2D3 and its analogues were smaller than vehicle-treated CAC-8-bearing mice. This finding suggested an inhibitory effect on tumor cell growth.
机译:这项研究的目的是确定1,25(OH)2D3及其类似物对肿瘤生长和体重,血浆离子钙,甲状旁腺激素相关蛋白(PTHrP)产生,骨吸收和分布的影响。 1,25(OH)2D3受体(VDR)在患有犬腺癌(CAC-8)的裸鼠体内的肿瘤中的表达。将37只裸鼠皮下植入CAC-8。植入后两周,将小鼠分为5组,每周一次腹膜内注射3次,共4周,使用5种不同的底物。给组I(非荷瘤小鼠)注射媒介物。第II组至第V组是注射以下药物的CAC-8小鼠:Grp。二,车辆;玻璃钢III,模拟V;玻璃钢IV,1,25(OH)2D3;和Grp。 V,EB1089。我们的结果表明,携带CAC-8的小鼠的体重(变化百分比)显着低于未携带瘤的小鼠(p <0.05)。用模拟V处理的带有CAC-8的小鼠的体重比用媒介物1,25(OH)2D3或EB1089处理的带有CAC-8的小鼠保持更好的体重。在用1,25(OH)2D3及其类似物治疗的带有CAC-8的小鼠中观察到肿瘤生长的减少;但是,与载体治疗的携带CAC-8的小鼠相比,这种减少没有统计学意义。所有携带CAC-8的小鼠均增加破骨细胞骨吸收和高钙血症。 VDR抗体对CAC-8的免疫组织化学染色显示,肿瘤细胞核内呈阳性反应。总之,与其他带有CAC-8的组相比,用类似物V处理的带有CAC-8的小鼠更活跃,并且保持更好的体重。尽管与无肿瘤小鼠相比,经等离子V处理的小鼠血浆离子钙的增加也没有显示高钙血症的毒性副作用。用1,25(OH)2D3及其类似物治疗的带有CAC-8的小鼠的肿瘤体积小于载剂治疗的带有CAC-8的小鼠。这一发现表明对肿瘤细胞生长具有抑制作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号